Revolution Medicines, Inc.
RVMD
$37.01
$0.531.45%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -56.40% | -44.03% | -37.52% | -71.14% | -75.27% |
| Total Depreciation and Amortization | 34.02% | 38.37% | 30.64% | 28.24% | 14.87% |
| Total Amortization of Deferred Charges | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Total Other Non-Cash Items | 94.18% | 29.42% | -23.42% | 28.13% | 20.15% |
| Change in Net Operating Assets | 250.60% | 766.35% | -98.90% | -1,127.01% | -298.34% |
| Cash from Operations | -34.35% | -31.77% | -59.01% | -84.96% | -109.76% |
| Capital Expenditure | -48.38% | -13.89% | -33.37% | -37.58% | -12.29% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 12.03% | 46.71% | -62.48% | -1,460.65% | -169.04% |
| Cash from Investing | 10.61% | 45.78% | -61.82% | -1,865.12% | -160.49% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 7,168.69% | 1,151.92% | 120.11% | -80.02% | -98.28% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -58.89% | -88.62% | -88.62% | 2,001,885.71% | 2,001,885.71% |
| Cash from Financing | 42.40% | 5.93% | -21.95% | 109.64% | 23.26% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 222.49% | 133.30% | -128.43% | -186.97% | -137.83% |